Blue Water Life Science Advisors’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Blue Water Life Science Advisors’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-992,086	Closed	-$2.88M	–	11
2022 Q3	$2.88M	Hold	992,086	–	–	1.16%	9
2022 Q2	$4.48M	Hold	992,086	–	–	2.44%	9
2022 Q1	$7.96M	Buy	992,086 +591,098	+147%	+$5.21M	3.78%	7
2021 Q4	$4.67M	Hold	400,988	–	–	1.43%	11
2021 Q3	$4.97M	Buy	+400,988	New	+$4.52M	1.62%	11

Other funds holding SLGC

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MAM

Madryn Asset Management New York $34.1M AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

Blue Water Life Science Advisors's SLGC Position: Q4 2022 in Review

Blue Water Life Science Advisors sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q4 2022, closing a stake of 992,086 shares — an estimated $2.88M sold.

Blue Water Life Science Advisors first reported a position in SLGC in Q3 2021 and held it in 5 quarters. The position peaked at $7.96M in Q1 2022. 140 funds tracked by Wall St. Rank hold SLGC as of Q4 2022.

Blue Water Life Science Advisors reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Blue Water Life Science Advisors sold 992,086 SomaLogic, Inc. Class A Common Stock shares in Q4 2022, an estimated $2.88M.
Blue Water Life Science Advisors first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 5 quarters.
Blue Water Life Science Advisors's SomaLogic, Inc. Class A Common Stock position peaked at $7.96M in Q1 2022.
140 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q4 2022.

Based on Blue Water Life Science Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.